tiprankstipranks
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: Irhythm Technologies (IRTC), Inogen (INGN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Irhythm Technologies (IRTCResearch Report) and Inogen (INGNResearch Report) with bullish sentiments.

Irhythm Technologies (IRTC)

In a report released today, David Saxon from Needham reiterated a Buy rating on Irhythm Technologies, with a price target of $185.00. The company’s shares closed last Thursday at $153.42, close to its 52-week high of $169.54.

According to TipRanks.com, Saxon is a 1-star analyst with an average return of -4.9% and a 35.1% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Globus Medical, and Cooper Co.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Irhythm Technologies with a $166.43 average price target, implying a 6.1% upside from current levels. In a report issued on August 1, J.P. Morgan also maintained a Buy rating on the stock with a $185.00 price target.

See the top stocks recommended by analysts >>

Inogen (INGN)

In a report released today, Michael Matson from Needham maintained a Buy rating on Inogen, with a price target of $45.00. The company’s shares closed last Thursday at $28.64, close to its 52-week low of $22.51.

According to TipRanks.com, Matson is a 4-star analyst with an average return of 4.0% and a 48.5% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Inogen with a $35.67 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on IRTC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed